BHLHE40/DEC1 programs epidermal Langerhans cell identity

Area of Science:

• Immunology
• Cell Biology
• Developmental Biology

Background:

• Langerhans cells (LCs) are vital immune cells in epithelia, essential for immune tolerance.
• TGF-β signaling pathways regulate LC development and epithelial identity, but downstream transcriptional factors are not fully understood.

Purpose of the Study:

• To identify novel transcriptional regulators of Langerhans cell lineage commitment and epithelial identity.
• To elucidate the role of BHLHE40 in TGF-β-mediated LC development.

Main Methods:

• Transcriptomic profiling of human hematopoietic progenitors undergoing LC differentiation.
• Lentiviral knockdown and overexpression of BHLHE40.
• Analysis of BHLHE40 expression in human skin and mouse models.
• Assessment of signaling pathway components (SMAD2/3) and marker expression (RUNX3, E-cadherin, EpCAM, TROP2, AXL).

Main Results:

• BHLHE40 (DEC1) is rapidly induced by TGF-β1 signaling during LC differentiation.
• BHLHE40 overexpression promotes LC differentiation, while its knockdown leads to monocyte/dendritic cell fates.
• Loss of BHLHE40 impairs SMAD2/3 phosphorylation, RUNX3 expression, and epithelial markers.
• BHLHE40 is downregulated in psoriatic LCs and its deficiency disrupts epidermal LC networks in mice.

Conclusions:

• BHLHE40 acts as a key transcriptional regulator linking TGF-β1 signaling to LC homeostasis.
• BHLHE40 is essential for maintaining LC lineage commitment and epithelial identity.
• Dysregulation of BHLHE40 may contribute to altered LC function in inflammatory conditions like psoriasis.